Review
Considerations in the design and production of small anti-receptor antibody forms: optimizing gains while reducing size
Affiliations
- PMID: 7584503
Item in Clipboard
Review
Considerations in the design and production of small anti-receptor antibody forms: optimizing gains while reducing size
Ther Immunol.
1994 Oct.
Abstract
Recent advances which have lead to the cloning of numerous immunoglobulin genes has resulted in the production of a variety of recombinant small antibody-like molecules. These smaller immunoglobulin derived molecules have potential for the development of diagnostic and pharmaceutical compounds. The considerations in the design and production of smaller antibody-like molecules and their clinical applications will be summarized in this review.
Similar articles
-
Pharmacokinetics and biodistribution of genetically-engineered antibodies.Q J Nucl Med. 1998 Dec;42(4):225-41. Q J Nucl Med. 1998. PMID: 9973838 Review.
-
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.Virology. 2001 Sep 15;288(1):29-35. doi: 10.1006/viro.2001.1014. Virology. 2001. PMID: 11543655
-
High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.J Mol Biol. 2002 Jan 4;315(1):1-8. doi: 10.1006/jmbi.2001.5221. J Mol Biol. 2002. PMID: 11771962
-
[Recombinant design and expression of human three-domain antibody against BoNTa].Wei Sheng Wu Xue Bao. 2005 Apr;45(2):223-5. Wei Sheng Wu Xue Bao. 2005. PMID: 15989265 Chinese.
-
Designer genes: recombinant antibody fragments for biological imaging.Q J Nucl Med. 2000 Sep;44(3):268-83. Q J Nucl Med. 2000. PMID: 11105590 Review.
Cited by
-
Structure-based design of immunologically active therapeutic peptides.Immunol Res. 1998;17(1-2):163-9. doi: 10.1007/BF02786441. Immunol Res. 1998. PMID: 9479578 Review.